The DOI matches its Crossref record; 80 of the 82 references it cites were found in a registry or an index.
International Consensus on Use of Continuous Glucose Monitoring
Open accessAbstract
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many countries, the benefits and utility of CGM are now recognized by national and international medical organizations for individuals with insulin-requiring diabetes and/or those at risk for hypoglycemia (16-21).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Correlations of fructosamine with HbA1c and mean blood glucose were examined in 4 observational studies.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [198]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The list of core CGM metrics has now been streamlined for use in clinical practice based on the expert opinion of this International Consensus Group (18).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“This recommendation was later endorsed at the aforementioned international consensus conference on CGM metrics (18) and is referenced as an example in the American Diabetes Association (ADA) 2019 Standards of Care (16) and in an update to the American Association of Clinical Endocrinologists (AACE) consensus on use of CGM (69).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“CGM helps characterize the timing, amplitude, and frequency of excursions [133–139], and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management [140–144].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [133]
The cited source says what the claim attributes to it.
In the citing paper
“In this context, CGM plays a central role by enabling visualization of glycemic trends and revealing patterns that are missed with capillary glucose testing [132, 133].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [133]
The cited source says what the claim attributes to it.
In the citing paper
“Our findings support the recent consensus conference recommendation (12, 13) that sensor glucose values ,54 mg/dL represent a more meaningful cut-off than 70 mg/dL to define clinically important hypoglycemia because CGM glucose levels below 54 mg/dL were uncommon, whereas most participants had some glucose levels of 55 to 69 mg/dL.”
From Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“The current consensus conferences have somewhat arbitrarily set time in ranges for CGM sensor glucose levels for patients with T1D, with time in target identified as being between 70 to 180 mg/dL (12,13).”
From Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study (2019) · cites this paper as [12]
In the citing paper
“Core glucose metrics determined by CGM, including TIR and GMI, provide more precise real-time and retrospective information about glycemic control.34”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893 · cited 2×
“severe hypoglycemia (26-37) [C,C,B,B,C,C,A,C,B,C,B].”
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., DeFronzo, R. A., EINHORN, D. F., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 879
Self-citationVariability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C., & Hart, G. K. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 853
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Self-citationBeck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Temelkova-Kurktschiev, T. S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K., & Markolf Hanefeld, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1830 · Cited by 543
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citationEffects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
Bry, L., Chen, P. C., & Sacks, D. B. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.153 · Cited by 523
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Self-citationthe SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Self-citationThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Self-citationEsposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Self-citationToward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Monnier, L., Colette, C., Wojtusciszyn, A., Dejager, S., Renard, E., Molinari, N., & Owens, D. R. (2017) · Diabetes Care · doi:10.2337/dc16-1769 · Cited by 390
Weinstock, R. S., Xing, D., Maahs, D. M., Michels, A., Rickels, M. R., Peters, A. L., Bergenstal, R. M., Harris, B., DuBose, S. N., Miller, K. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1589 · Cited by 338
Self-citationHbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Rodbard, D. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0132 · Cited by 324
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Self-citationEffectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2011) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 312
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., Young-Hyman, D. L., Schlundt, D. G., & Clarke, W. L. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1870 · Cited by 309
Self-citationBergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307 · cited 1×
“in a consensus conference held in 2012 (82) [E] and is recommended by this consensus group as a standard for visualization of CGM data.”
BackgroundSelf-citationRacial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306
Self-citationIntensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch, I. B. (2015) · Diabetes Care · doi:10.2337/dc14-2898 · Cited by 291
Self-citationGlucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes
Kovatchev, B. P., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc15-2035 · Cited by 276
Self-citationHbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes
Lipska, K. J., Warton, E. M., Huang, E. S., Moffet, H. H., Inzucchi, S. E., Krumholz, H. M., & Karter, A. J. (2013) · Diabetes Care · doi:10.2337/dc13-0610 · Cited by 254
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244
Glucose Variability: Where It Is Important and How to Measure It
DeVries, J. H. (2013) · Diabetes · doi:10.2337/db12-1610 · Cited by 236
Self-citationAssessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
Self-citationService, F. J. (2013) · Diabetes · doi:10.2337/db12-1396 · Cited by 228
Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson, A. L., Mullen, D. M., & Bergenstal, R. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0024 · Cited by 181
Self-citationHermanides, J., Nørgaard, K., Bruttomesso, D., Mathieu, C., Frid, A. H., Dayan, C. M., Diem, P., Fermon, C., Wentholt, I. M. E., Hoekstra, J. B. L., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03256.x · Cited by 171
Self-citationKropff, J., Choudhary, P., Neupane, S., Barnard-Kelly, K. D., Bain, S. C., Kapitza, C., Forst, T. M., Link, M., DEHENNIS, A. D., & DeVries, J. H. (2016) · Diabetes Care · doi:10.2337/dc16-1525 · Cited by 171
Self-citationIron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US
FORD, E. S., COWIE, C. C., LI, C., HANDELSMAN, Y., & BLOOMGARDEN, Z. T. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00100.x · Cited by 165
Glucose variability measures and their effect on mortality: a systematic review
Eslami, S., Taherzadeh, Z., Schultz, M. J., & Abu–Hanna, A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2129-5 · Cited by 151
Reichard, P., & Pihl, M. (1994) · Diabetes · doi:10.2337/diab.43.2.313 · Cited by 147
Bergenstal, R. M. (2015) · Diabetes Care · doi:10.2337/dc15-0099 · Cited by 140
Self-citationCox, D. J., Kovatchev, B. P., Julian, D. M., Gonder-Frederick, L. A., Polonsky, W. H., Schlundt, D. G., & Clarke, W. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989471 · Cited by 137
Self-citationFranciosi, M., Lucisano, G., Pellegrini, F., Cantarello, A., Consoli, A., Cucco, L., Ghidelli, R., Sartore, G., Sciangula, L., Nicolucci, A., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03268.x · Cited by 137
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring
Xing, D., Kollman, C., Beck, R. W., Tamborlane, W. V., Laffel, L., Buckingham, B. A., Wilson, D. M., Weinzimer, S., Fiallo-Scharer, R., & Ruedy for the Juvenile Diabetes Research Foundation Continuo, K. J. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0156 · Cited by 131
Rodbard, D., Bailey, T. S., Jovanovič, L., Zisser, H., Kaplan, R. A., & Garg, S. K. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0077 · Cited by 131
Self-citationCampbell, M. S., Schatz, D., Chen, V., Wong, J. C., Steck, A. K., Tamborlane, W. V., Smith, J., Beck, R. W., Cengiz, E., Laffel, L. M., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12067 · Cited by 126
Self-citationQu, Y., Jacober, S. J., Zhang, Q., Wolka, L. L., & DeVries, J. H. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0099 · Cited by 126
Self-citationThe Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang, E. S., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Lee, J. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Tamborlane, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 118
Self-citationHuman Brain Glycogen Metabolism During and After Hypoglycemia
Öz, G., Kumar, A. F., Rao, J. P., Kodl, C. T., Chow, L. S., Eberly, L. E., & Seaquist, E. R. (2009) · Diabetes · doi:10.2337/db09-0226 · Cited by 114
Davis, S. N., Mann, S., Galassetti, P., Neill, R. A., Tate, D., Ertl, A. C., & Costa, F. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1897 · Cited by 100
Riveline, J., Schaepelynck, P., Chaillous, L., Renard, É., Sola‐Gazagnes, A., Penfornis, A., Tubiana‐Rufi, N., Sulmont, V., Catargi, B., Lukas, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2021 · Cited by 99
Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Davis, M. R., Mellman, M., & Shamoon, H. (1992) · Diabetes · doi:10.2337/diab.41.10.1335 · Cited by 98
Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes
Wolffenbuttel, B. H. R., Herman, W. H., Gross, J. L., Dharmalingam, M., Jiang, H. H., & Hardin, D. S. (2013) · Diabetes Care · doi:10.2337/dc12-2711 · Cited by 94
Garg, S. K., Voelmle, M. K., Beatson, C. R., Miller, H. A., Crew, L. B., Freson, B. J., & Hazenfield, R. M. (2011) · Diabetes Care · doi:10.2337/dc10-1852 · Cited by 85
Self-citationNew, J. P., Ajjan, R., Pfeiffer, A. F. H., & Freckmann, G. (2015) · Diabetic Medicine · doi:10.1111/dme.12713 · Cited by 83
The Challenges of Measuring Glycemic Variability
Rodbard, D. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600328 · Cited by 83
El-Laboudi, A. H., Godsland, I. F., Johnston, D. G., & Oliver, N. S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0146 · Cited by 83
McQueen, R. B., Ellis, S. L., Campbell, J. D., Nair, K. V., & Sullivan, P. W. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-13 · Cited by 75
Herman, W. H. (2016) · Diabetes Care · doi:10.2337/dc15-2686 · Cited by 68
Obermaier, K., Schmelzeisen‐Redeker, G., Schoemaker, M., Klötzer, H.-M., Kirchsteiger, H., Eikmeier, H., & del Re, L. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700404 · Cited by 66
Are risk indices derived from CGM interchangeable with SMBG-Based indices?
Fabris, C., Patek, S. D., & Breton, M. D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815599177 · Cited by 52
Kempf, K., Kruse, J., & Martin, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0116 · Cited by 48
Rachmiel, M., Landau, Z., Boaz, M., Aronovitch, K. M., Loewenthal, N., Ben‐Ami, M., Levy‐Shraga, Y., Modan‐Moses, D., Haim, A., Abiri, S., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0643-6 · Cited by 45
Ly, T. T., Brnabic, A. J. M., Eggleston, A., Kolivos, A., McBride, M. E., Schrover, R., & Jones, T. W. (2014) · Value in Health · doi:10.1016/j.jval.2014.05.008 · Cited by 43
Self-citationRoze, S., Smith‐Palmer, J., Valentine, W. J., Cook, M., Jethwa, M., de Portu, S., & Pickup, J. C. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1113979 · Cited by 42
Health‐economic analysis of real‐time continuous glucose monitoring in people with Type 1 diabetes
Roze, S., Saunders, R., Brandt, A. ‐., de Portu, S., Papo, N. L., & JENDLE, J. H. (2014) · Diabetic Medicine · doi:10.1111/dme.12661 · Cited by 41
Roze, S., Smith‐Palmer, J., Valentine, W. J., Payet, V., de Portu, S., Papo, N. L., Cucherat, M., & Hanaire, H. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0224 · Cited by 37
Structured self‐monitoring of blood glucose reduces glycated hemoglobin in insulin‐treated diabetes
Kato, N., Cui, J., & Kato, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12072 · Cited by 36
Haffner, S. M. (2001) · Circulation · doi:10.1161/01.cir.103.3.346 · Cited by 35
Kovatchev, B. P., Flacke, F., Sieber, J., & Breton, M. D. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0224 · Cited by 34
Self-citationBolli, G. B. (1997) · PubMed · Cited by 32
Prediction and prevention of type 1 diabetes: what can be expected from genetics?
Jc, C., Lotton, C., & Bourgnères, P. (1997) · PubMed · Cited by 27
Ethnic/racial determinants of glycemic markers in a UK sample
Shipman, K. E., Jawad, M., Sullivan, K. M., Ford, C., & Gama, R. M. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0703-y · Cited by 23
Flagged first, then by citations
2 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationKDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 915
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Self-citation
Metadata
- Authors
- Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., Beck, R., Bosi, E., Buckingham, B., Cobelli, C., Dassau, E., Doyle, F. J., Heller, S., Hovorka, R., Jia, W., Jones, T., Kordonouri, O., Kovatchev, B., Kowalski, A., Laffel, L., Maahs, D., Murphy, H. R., Nørgaard, K., Parkin, C. G., Renard, E., Saboo, B., Scharf, M., Tamborlane, W. V., Weinzimer, S. A., & Phillip, M.
- Affiliations
- Kinderkrankenhaus auf der Bult (DE)
- Schneider Children's Medical Center (IL)
- University of Ljubljana (SI)
- Park Nicollet Health Services (US)
- Close Concerns (United States) (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Colorado Denver (US)
- Science & Co, Düsseldorf, Germany
- University of Washington (US)
- King's College London (GB)
- Jaeb Center for Health Research (US)
- Vita-Salute San Raffaele University (IT)
- Stanford Medicine (US)
- University of Padua (IT)
- Harvard University (US)
- University of Sheffield (GB)
- University of Cambridge (GB)
- Shanghai Jiao Tong University (CN)
- Telethon Kids Institute and School of Paediatrics and Child Health, The University of Western Australia, and Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Australia
- University of Virginia (US)
- Breakthrough T1D (US)
- Joslin Diabetes Center (US)
- University of East Anglia (GB)
- Hvidovre Hospital (DK)
- CGParkin Communications, Boulder City, NV
- Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, and Institute of Functional Genomics, University of Montpellier, and INSERM Clinical Investigation Centre, Montpellier, France
- DiaCare, Ahmedabad, Gujarat, India
- Hospital Nossa Senhora das Graças (BR)
- Yale University (US)
- Corresponding author
- Danne, Thomas
- ORCID
- Danne, Thomas
- Nimri, Revital
- Battelino, Tadej
- Bergenstal, Richard M.
- Close, Kelly L.
- DeVries, J. Hans
- Garg, Satish
- Heinemann, Lutz
- Hirsch, Irl
- Amiel, Stephanie A.
- Beck, Roy
- Bosi, Emanuele
- Buckingham, Bruce
- Cobelli, Claudio
- Dassau, Eyal
- Doyle, Francis J.
- Heller, Simon
- Hovorka, Roman
- Jia, Weiping
- Jones, Tim
- Kordonouri, Olga
- Kovatchev, Boris
- Kowalski, Aaron
- Laffel, Lori
- Maahs, David
- Murphy, Helen R.
- Nørgaard, Kirsten
- Parkin, Christopher G.
- Saboo, Banshi
- Tamborlane, William V.
- Weinzimer, Stuart A.
- Phillip, Moshe
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-11-10
- Volume
- 40
- Issue
- 12
- Pages
- 1631-1640
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6467165
- OpenAlex
- W2770616601
- Cited by
- 2,069
- References
- 82
- Citations by year
- 2026: 175 · 2025: 227 · 2024: 241 · 2023: 247 · 2022: 281 · 2021: 298 · 2020: 271 · 2019: 210 · 2018: 110 · 2017: 2
- FWCI
- 128.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- American Diabetes Association
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Leona M. and Harry B. Helmsley Charitable Trust
- Bigfoot Biomedical
- Insulet Corporation
- Dexcom
- Jaeb Center for Health Research
- National Institute for Health and Care Research (NF-SI-0515-10079, CDF-2013-06-035)
- Bayer HealthCare
- Novo Nordisk
- Roche Diabetes Care
- Abbott Diabetes Care
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK116074)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, glycemic control, HbA1c, HbA1c limitations, hypoglycemia, postprandial hyperglycemia, diabetes management, real-time CGM, diabetes complications, expert consensus recommendations
- MeSH terms
- Blood Glucose, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, International Agencies, Physicians, Reference Standards, Research Personnel, Blood Glucose Self-Monitoring, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
